Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
申请人:Bayer Corporation
公开号:US06353006B1
公开(公告)日:2002-03-05
This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents
申请人:——
公开号:US20030207865A1
公开(公告)日:2003-11-06
This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
[EN] AROYL SUBSTITUTED TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF<br/>[FR] COMPOSÉ TRICYCLIQUE SUBSTITUÉ PAR AROYLE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 芳甲酰取代的三环化合物及其制法和用途
The present invention provides compounds of Formula (I) which can be used as ACC inhibitors and potently as therapeutic agents against diseases mediated by ACC.
The present invention provides compounds of Formula (I) which can be used as ACC inhibitors and potently as therapeutic agents against diseases mediated by ACC.